Dr. David Aaron Petty, DO

Dr. Petty practices at George E. Wahlen Department of Veterans Affairs Medical Center in Salt Lake City, Utah, part of Veterans Health Administration.

Dr. Petty's NPI, 1376877795, was assigned on October 1, 2009. Dr. Petty holds Idaho license O-0796.

Dr. Petty's primary practice is George E. Wahlen Department of Veterans Affairs Medical Center, at 500 Foothill Blvd., Salt Lake City, UT 84148 in Salt Lake County. The practice phone is (801) 584-1211.

Dr. Petty's primary practice is George E. Wahlen Department of Veterans Affairs Medical Center in Salt Lake City, Utah, part of Veterans Health Administration. Dr. Petty is also affiliated with Mountain View Hospital. The medical group on file is Idaho Allergy And Asthma Clinic. Dmand AI also links Dr. Petty to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Petty practices, 7 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Petty's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dmand AI has Dr. Petty's licenses on file in 2 states: Idaho and Tennessee.

CMS data shows 2,143 Medicare services from Dr. Petty across 10 procedure codes in 2024, for 185 Medicare patients. Medicare paid $27,702 for them. Every service was in an office.

CMS counts 185 Medicare patients who saw Dr. Petty in 2024. The largest group is 65 to 74, with 108 patients. 69% of them have high blood pressure, and 63% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Petty's median patient age at 43, with 62% women.

In 2024, Dr. Petty wrote 892 Medicare Part D claims for 102 patients. 56% of them were for generic drugs. CMS names the drug for 766 of them, across 25 drugs with 11 or more claims each, at $1,925,788 in total drug cost. In 2023, CMS named 741 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Petty for performance year 2024, reported as part of a group. Dr. Petty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Petty as offering telehealth.

CMS Open Payments shows 691 general payments to Dr. Petty from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,743.